(Q41024564)

25 September 2017

title

MicroRNA-148a represents an independent prognostic marker in bladder cancer (English)

1 reference

25 September 2017

1 reference

Lin Ma

1

1 reference

25 September 2017

Zhishun Xu

series ordinal

2

1 reference

25 September 2017

Chao Xu

series ordinal

3

1 reference

25 September 2017

Xianzhou Jiang

series ordinal

4

1 reference

25 September 2017

publication date

23 December 2015

1 reference

25 September 2017

1 reference

25 September 2017

volume

37

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

7915-7920

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4688-0

25 September 2017

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Current chemotherapeutic options for the treatment of advanced bladder cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Recent advances in treatment of advanced urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

microRNA-21 Regulates Cell Proliferation and Migration and Cross Talk with PTEN and p53 in Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MiR-148a inhibits angiogenesis by targeting ERBB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

RETRACTED: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4688-0

Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

First- and second-line therapy for metastatic urothelial carcinoma of the bladder

1 reference

12 December 2020

[MicroRNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells].

1 reference

12 December 2020

Targeted therapy in advanced urothelial carcinoma

1 reference

12 December 2020

miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1.

1 reference

12 December 2020

Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening

1 reference

12 December 2020

Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis

1 reference

12 December 2020

10.1007/S13277-015-4688-0

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

1025366942

0 references

1 reference